THE CYTOKERATIN FILAMENT-AGGREGATING PROTEIN FILAGGRIN IS THE TARGET OF THE SO-CALLED ANTIKERATIN ANTIBODIES, AUTOANTIBODIES SPECIFIC FOR RHEUMATOID-ARTHRITIS
M. Simon et al., THE CYTOKERATIN FILAMENT-AGGREGATING PROTEIN FILAGGRIN IS THE TARGET OF THE SO-CALLED ANTIKERATIN ANTIBODIES, AUTOANTIBODIES SPECIFIC FOR RHEUMATOID-ARTHRITIS, The Journal of clinical investigation, 92(3), 1993, pp. 1387-1393
In rheumatoid arthritis (RA), the high diagnostic value of serum antib
odies to the stratum corneum of rat esophagus epithelium has been wide
ly reported. These so-called ''antikeratin antibodies,'' detected by i
ndirect immunofluorescence, were found to be autoantibodies since they
also labeled human epidermis. Despite their name, the actual target o
f these autoantibodies was not known. In this study, a 40-kD protein (
designated as 40K), extracted from human epidermis and specifically im
munodetected by 75% of RA sera, was purified and identified as a neutr
al / acidic isoform of basic filaggrin, a cytokeratin filament-aggrega
ting protein, by peptide mapping studies and by the following evidence
s: (a) mAbs specific for filaggrin reacted with the 40K protein; (b) t
he autoantibodies, affinity-purified from RA sem on the 40K protein, i
mmunodetected purified filaggrin; (c) the reactivity of RA sera to the
40K protein was abolished after immunoadsorption with purified filagg
rin; (d) the 40K protein and filaggrin had similar amino acid composit
ions. Furthermore, autoantibodies against the 40K protein and the so-c
alled ''antikeratin antibodies'' were shown, by immunoadsorption exper
iments, to be largely the same. The identification of filaggrin as a R
A-specific autoantigen could contribute to the understanding of the pa
thogenesis of this disease and, ultimately, to the development of meth
ods for preventing the autoimmune response.